CORRELATION OF RECIPIENT FACTORS WITH THE COURSE OF LYMPHOCYTES AFTER ALEMTUZUMAB INDUCTION IN RENAL TRANSPLANTATION

被引：0
|
作者：
Weissenbacher, A. [1 ]
Kimelman, M. [1 ]
Hautz, T. [1 ]
Ulmer, H. [2 ]
Boesmueller, C. [1 ]
Maglione, M. [1 ]
Margreiter, R. [1 ]
Oellinger, R. [1 ]
Pratschke, J. [1 ]
Schneeberger, S. [1 ]
机构：
[1] Med Univ Innsbruck, Univ Klin Visceral Transplantat & Thoraxchirurg, Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Med Stat Informat & Gesundheitsokon, Innsbruck, Austria
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
    Tan, H. P.
    Kaczorowski, D. J.
    Basu, A.
    Unruh, M.
    McCauley, J.
    Wu, C.
    Donaldson, J.
    Dvorchik, I.
    Kayler, L.
    Marcos, A.
    Randhawa, P.
    Smetanka, C.
    Starzl, T. E.
    Shapiro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) : 2409 - 2417
  • [32] Kidney After Nonrenal Transplantation-The Impact of Alemtuzumab Induction
    Shapiro, Ron
    Basu, Amit
    Tan, Henkie P.
    Morgan, Claire
    Sharma, Vivek
    Blisard, Deanna
    Randhawa, Parmjeet S.
    Dvorchik, Igor
    McCauley, Jerry
    Ellis, Demetrius
    Marsh, J. Wallis
    Webber, Steven
    Kurland, Geoffrey
    McCurry, Kenneth R.
    Abu-Elmagd, Kareem
    Mazariegos, George
    Starzl, Thomas E.
    TRANSPLANTATION, 2009, 88 (06) : 799 - 802
  • [33] Hypertension in renal transplantation: donor and recipient risk factors
    Ducloux, D
    Motte, G
    Kribs, M
    Abdelfatah, AB
    Bresson-Vautrin, C
    Rebibou, JM
    Chalopin, JM
    CLINICAL NEPHROLOGY, 2002, 57 (06) : 409 - 413
  • [34] Basiliximab Induction in Renal Transplantation: Histopathologic Correlation
    Duggal, R.
    Rana, A.
    Bansal, S.
    Sharma, R.
    Jha, P.
    Kher, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 258 - 258
  • [35] Basiliximab Induction in Renal Transplantation: Histopathologic Correlation
    Duggal, R.
    Rana, A.
    Bansal, S.
    Sharma, R.
    Jha, P.
    Kher, V.
    TRANSPLANTATION, 2014, 98 : 258 - 258
  • [36] Lower Tacrolimus Goal Levels after Routine Induction Therapy with Alemtuzumab in Cardiac Transplantation: Impact on Renal Outcomes
    Teuteberg, J. J.
    Zomak, R.
    Navoney, M.
    Kormos, R. L.
    Toyoda, Y.
    McNamara, D.
    Shullo, M. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 130 - 131
  • [37] Long-Term Outcomes after Alemtuzumab Induction in Lung Transplantation
    Shyu, S.
    Dew, M. A.
    Dabbs, A. De Vito
    Crespo, M.
    Zaldonts, D. B.
    Johnson, B. A.
    Studer, S. M.
    Toyoda, Y.
    Bermudez, C. A.
    Hattler, B. G.
    Pilewski, J. M.
    McCurry, K. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S68 - S68
  • [38] INCIDENCE OF MALIGANCY AFTER KIDNEY TRANSPLANTATION WITH ALEMTUZUMAB AND OTHER INDUCTION AGENTS
    Nepal, Manish
    Al-laham, Ammar
    Wood, Craig
    Govindasamy, Rajesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A72 - A72
  • [39] Outcome of Short Course Antithymocte Globulin Induction after Renal Transplantation in Elderly Individuals
    Flohr, Tanya R.
    Bonatti, Hugo
    Schmitt, Timothy M.
    Sawyer, Robert G.
    Pruett, Timothy L.
    Brayman, Kenneth L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 515 - 515
  • [40] Our unique experience with low dose Alemtuzumab as induction agent in renal transplantation
    Champannoor, Cherin
    Sundar, Divya
    Matthew, Milly
    Kumar, Prem
    Vaidya, Anil
    Abraham, Georgi
    TRANSPLANTATION, 2024, 108 (09) : 340 - 340
12345